{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:43:39Z","timestamp":1770147819605,"version":"3.49.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11154-025-09961-w","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T01:50:28Z","timestamp":1743731428000},"page":"593-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ectopic GHRH production: revisiting a rare cause of acromegaly"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6465-0972","authenticated-orcid":false,"given":"Matheo A. M.","family":"Stumpf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1447-1754","authenticated-orcid":false,"given":"Nathalie Oliveira","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio Carlos","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe H.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8201-6756","authenticated-orcid":false,"given":"Andrea","family":"Glezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4336-1271","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel S.","family":"Jallad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"14","key":"9961_CR1","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1073\/pnas.81.14.4302","volume":"81","author":"N Ling","year":"1984","unstructured":"Ling N, Esch F, B\u00f6hlen P, Brazeau P, Wehrenberg WB, Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic Somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci U S A. 1984;81(14):4302\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9961_CR2","first-page":"35","volume":"50","author":"KE Mayo","year":"1995","unstructured":"Mayo KE, Godfrey PA, Suhr ST, Kulik DJ, Rahal JO. Growth hormone-releasing hormone: synthesis and signaling. Recent Prog Horm Res. 1995;50:35\u201373.","journal-title":"Recent Prog Horm Res"},{"key":"9961_CR3","doi-asserted-by":"crossref","unstructured":"Siejka A, Lawnicka H, Fakir S, Barabutis N. Growth hormone - releasing hormone in the immune system. Rev Endocr Metab Disord Published Online Oct 7, 2024.","DOI":"10.1007\/s11154-024-09913-w"},{"issue":"24","key":"9961_CR4","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355(24):2558\u201373.","journal-title":"N Engl J Med"},{"issue":"4572","key":"9961_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1126\/science.6812220","volume":"218","author":"R Guillemin","year":"1982","unstructured":"Guillemin R, Brazeau P, B\u00f6hlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982;218(4572):585\u20137.","journal-title":"Science"},{"issue":"5","key":"9961_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1172\/JCI110708","volume":"70","author":"MO Thorner","year":"1982","unstructured":"Thorner MO, Perryman RL, Cronin MJ, et al. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest. 1982;70(5):965\u201377.","journal-title":"J Clin Invest"},{"issue":"6","key":"9961_CR7","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1210\/jc.2011-2930","volume":"97","author":"L Garby","year":"2012","unstructured":"Garby L, Caron P, Claustrat F, et al. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases. J Clin Endocrinol Metab. 2012;97(6):2093\u2013104.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9961_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/EJE-21-0216","volume":"185","author":"S Crisafulli","year":"2021","unstructured":"Crisafulli S, Luxi N, Sultana J, et al. Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol. 2021;185(2):251\u201363.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"9961_CR9","doi-asserted-by":"publisher","first-page":"101877","DOI":"10.1016\/j.beem.2024.101877","volume":"38","author":"P Fainstein-Day","year":"2024","unstructured":"Fainstein-Day P, Ullmann TE, Dalurzo MCL, Sevlever GE, Smith DE. The clinical and biochemical spectrum of ectopic acromegaly. Best Pract Res Clin Endocrinol Metab. 2024;38(3):101877.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"9961_CR10","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1093\/annonc\/12.suppl_2.S89","volume":"12","author":"M Doga","year":"2001","unstructured":"Doga M, Bonadonna S, Burattin A, Giustina A. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. Ann Oncol. 2001;12(Suppl 2):S89\u201394.","journal-title":"Ann Oncol"},{"issue":"3","key":"9961_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1210\/edrv-9-3-357","volume":"9","author":"T Sano","year":"1988","unstructured":"Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev. 1988;9(3):357\u201373.","journal-title":"Endocr Rev"},{"issue":"1","key":"9961_CR12","first-page":"13","volume":"109","author":"K Oberg","year":"1985","unstructured":"Oberg K, Norheim I, Wide L. Serum growth hormone in patients with carcinoid tumours; basal levels and response to glucose and thyrotrophin releasing hormone. Acta Endocrinol (Copenh). 1985;109(1):13\u20138.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"9961_CR13","doi-asserted-by":"publisher","first-page":"867965","DOI":"10.3389\/fendo.2022.867965","volume":"13","author":"I Zendran","year":"2022","unstructured":"Zendran I, Gut G, Ka\u0142u\u017cny M, Zawadzka K, Bolanowski M. Acromegaly caused by ectopic growth hormone releasing hormone secretion: A review. Front Endocrinol. 2022;13:867965.","journal-title":"Front Endocrinol"},{"issue":"1","key":"9961_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, et al. Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024;27(1):7\u201322.","journal-title":"Pituitary"},{"key":"9961_CR15","doi-asserted-by":"publisher","first-page":"807054","DOI":"10.3389\/fendo.2021.807054","volume":"12","author":"X Guo","year":"2022","unstructured":"Guo X, Zhang R, Zhang D, et al. Hyperprolactinemia and hypopituitarism in acromegaly and effect of pituitary surgery: Long-Term Follow-up on 529 patients. Front Endocrinol. 2022;12:807054.","journal-title":"Front Endocrinol"},{"issue":"3","key":"9961_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.mehy.2008.08.030","volume":"72","author":"DC Skinner","year":"2009","unstructured":"Skinner DC. Rethinking the stalk effect: A new hypothesis explaining suprasellar Tumor-Induced hyperprolactinemia. Med Hypotheses. 2009;72(3):309\u201310.","journal-title":"Med Hypotheses"},{"issue":"1","key":"9961_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2265.1989.tb03728.x","volume":"30","author":"O Serri","year":"1989","unstructured":"Serri O, Somma M, Rasio E, Brazeau P. Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas. Clin Endocrinol (Oxf). 1989;30(1):65\u201375.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"9961_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1210\/jcem-59-4-705","volume":"59","author":"G Sassolas","year":"1984","unstructured":"Sassolas G, Chatelain P, Cohen R, et al. Effects of human pancreatic tumor growth hormone-releasing hormone (hpGRH1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men. J Clin Endocrinol Metab. 1984;59(4):705\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9961_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","volume":"32","author":"J Trouillas","year":"2008","unstructured":"Trouillas J, Labat-Moleur F, Sturm N, et al. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol. 2008;32(4):534\u201343.","journal-title":"Am J Surg Pathol"},{"key":"9961_CR20","doi-asserted-by":"publisher","first-page":"1473167","DOI":"10.3389\/fendo.2024.1473167","volume":"15","author":"A Gupta","year":"2024","unstructured":"Gupta A, Kasaliwal R, Das L, et al. Ectopic acromegaly with tumoral range hyperprolactinemia and apoplexy with a dramatic regression of pituitary hyperplasia. Front Endocrinol. 2024;15:1473167.","journal-title":"Front Endocrinol"},{"issue":"5","key":"9961_CR21","first-page":"648","volume":"65","author":"EB Lamback","year":"2021","unstructured":"Lamback EB, Henriques DG, Vazquez-Borrego MC, et al. Growth hormone-releasing hormone-secreting pulmonary neuroendocrine tumor associated with pituitary hyperplasia and somatotropinoma. Arch Endocrinol Metab. 2021;65(5):648\u201363.","journal-title":"Arch Endocrinol Metab"},{"issue":"7","key":"9961_CR22","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","volume":"31","author":"M Pavel","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844\u201360.","journal-title":"Ann Oncol"},{"issue":"15","key":"9961_CR23","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.3390\/jcm12155138","volume":"12","author":"Q Sultana","year":"2023","unstructured":"Sultana Q, Kar J, Verma A, et al. A comprehensive review on neuroendocrine neoplasms: presentation, pathophysiology and management. J Clin Med. 2023;12(15):5138.","journal-title":"J Clin Med"},{"issue":"8","key":"9961_CR24","doi-asserted-by":"publisher","first-page":"e3313","DOI":"10.1210\/clinem\/dgac274","volume":"107","author":"I Potorac","year":"2022","unstructured":"Potorac I, Bonneville JF, Daly AF, et al. Pituitary MRI features in acromegaly resulting from ectopic GHRH secretion from a neuroendocrine tumor: analysis of 30 cases. J Clin Endocrinol Metab. 2022;107(8):e3313\u201320.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9961_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrendo.2014.64","volume":"10","author":"A Di Ieva","year":"2014","unstructured":"Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K. Aggressive pituitary adenomas\u2013diagnosis and emerging treatments. Nat Rev Endocrinol. 2014;10(7):423\u201335.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"9961_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","volume":"120","author":"WA Hall","year":"1994","unstructured":"Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med. 1994;120(10):817\u201320.","journal-title":"Ann Intern Med"},{"issue":"2","key":"9961_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1530\/ERC-14-0305","volume":"22","author":"I Potorac","year":"2015","unstructured":"Potorac I, Petrossians P, Daly AF, et al. Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. Endocr Relat Cancer. 2015;22(2):169\u201377.","journal-title":"Endocr Relat Cancer"},{"key":"9961_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13244-021-00986-8","volume":"12","author":"O Onder","year":"2021","unstructured":"Onder O, Yarasir Y, Azizova A, Durhan G, Onur MR, Ariyurek OM. Errors, discrepancies and underlying bias in radiology with case examples: a pictorial review. Insights Imaging. 2021;12:51.","journal-title":"Insights Imaging"},{"issue":"4","key":"9961_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s11102-009-0205-z","volume":"14","author":"S Daud","year":"2011","unstructured":"Daud S, Hamrahian AH, Weil RJ, Hamaty M, Prayson RA, Olansky L. Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration? Pituitary. 2011;14(4):414\u20137.","journal-title":"Pituitary"},{"issue":"1\u20132","key":"9961_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0022-1759(86)90240-1","volume":"94","author":"OH Pescovitz","year":"1986","unstructured":"Pescovitz OH, Gelato MC, Bundy M, Loriaux DL, Merriam GR, Pescovitz MD. Production of monoclonal antibodies against human growth hormone releasing hormone and their use in an enzyme-linked immunosorbent assay (ELISA). J Immunol Methods. 1986;94(1\u20132):257\u201362.","journal-title":"J Immunol Methods"},{"issue":"3","key":"9961_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0009-8981(91)90055-H","volume":"202","author":"CY Zhang","year":"1991","unstructured":"Zhang CY, Yamasaki R, Mitsuhashi S, Takahashi H, Bando H, Saito S. Radioimmunoassay of growth hormone-releasing hormone (GHRH) with a polyclonal antibody against synthetic GHRH(1\u201329)-Gly4-Cys-NH2: method and clinical studies. Clin Chim Acta. 1991;202(3):243\u201354.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"9961_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ando.2012.09.004","volume":"73","author":"F Borson-Chazot","year":"2012","unstructured":"Borson-Chazot F, Garby L, Raverot G, et al. Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery. Ann Endocrinol (Paris). 2012;73(6):497\u2013502.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"9961_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11102-010-0226-7","volume":"15","author":"PW Butler","year":"2012","unstructured":"Butler PW, Cochran CS, Merino MJ, Nguyen DM, Schrump DS, Gorden P. Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy. Pituitary. 2012;15(2):260\u20135.","journal-title":"Pituitary"},{"issue":"4","key":"9961_CR34","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1210\/jc.2004-2156","volume":"90","author":"MC Zatelli","year":"2005","unstructured":"Zatelli MC, Maffei P, Piccin D, et al. Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid. J Clin Endocrinol Metab. 2005;90(4):2104\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9961_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1210\/jc.2008-1712","volume":"94","author":"M van Hoek","year":"2009","unstructured":"van Hoek M, Hofland LJ, de Rijke YB, et al. Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies. J Clin Endocrinol Metab. 2009;94(2):428\u201333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9961_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1210\/jcem-59-5-846","volume":"59","author":"MO Thorner","year":"1984","unstructured":"Thorner MO, Frohman LA, Leong DA, et al. Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab. 1984;59(5):846\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9961_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11154-021-09631-7","volume":"22","author":"A Pirasteh","year":"2021","unstructured":"Pirasteh A, Lovrec P, Bodei L. Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities. Rev Endocr Metab Disord. 2021;22(3):539\u201352.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"9961_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2217\/ije.14.40","volume":"2","author":"JE Maxwell","year":"2015","unstructured":"Maxwell JE, Howe JR. Imaging in neuroendocrine tumors: an update for the clinician. Int J Endocr Oncol. 2015;2(2):159\u201368.","journal-title":"Int J Endocr Oncol"},{"issue":"5","key":"9961_CR39","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3171\/2016.5.JNS16828","volume":"126","author":"VM Ravindra","year":"2017","unstructured":"Ravindra VM, Raheja A, Corn H, et al. Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report. J Neurosurg. 2017;126(5):1725\u201330.","journal-title":"J Neurosurg"},{"issue":"25","key":"9961_CR40","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1056\/NEJM200006223422504","volume":"342","author":"F Beuschlein","year":"2000","unstructured":"Beuschlein F, Strasburger CJ, Siegerstetter V, et al. Acromegaly caused by secretion of growth hormone by a non-Hodgkin\u2019s lymphoma. N Engl J Med. 2000;342(25):1871\u20136.","journal-title":"N Engl J Med"},{"issue":"748","key":"9961_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/pgmj.64.748.145","volume":"64","author":"HJ Southgate","year":"1988","unstructured":"Southgate HJ, Archbold GP, el-Sayed ME, Wright J, Marks V. Ectopic release of GHRH and ACTH from an adenoid cystic carcinoma resulting in acromegaly and complicated by pituitary infarction. Postgrad Med J. 1988;64(748):145\u20138.","journal-title":"Postgrad Med J"},{"issue":"1","key":"9961_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM198501033120103","volume":"312","author":"S Melmed","year":"1985","unstructured":"Melmed S, Ezrin C, Kovacs K, Goodman RS, Frohman LA. Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. N Engl J Med. 1985;312(1):9\u201317.","journal-title":"N Engl J Med"},{"issue":"1","key":"9961_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/1097-0142(19930101)71:1<66::AID-CNCR2820710112>3.0.CO;2-U","volume":"71","author":"S Ezzat","year":"1993","unstructured":"Ezzat S, Ezrin C, Yamashita S, Melmed S. Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor. Cancer. 1993;71(1):66\u201370.","journal-title":"Cancer"},{"issue":"3","key":"9961_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1507\/endocrj.42.331","volume":"42","author":"Y Shintani","year":"1995","unstructured":"Shintani Y, Yoshimoto K, Horie H, et al. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features. Endocr J. 1995;42(3):331\u201340.","journal-title":"Endocr J"},{"issue":"4","key":"9961_CR45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jtcvs.2004.02.033","volume":"128","author":"K Athanassiadi","year":"2004","unstructured":"Athanassiadi K, Exarchos D, Tsagarakis S, Bellenis I. Acromegaly caused by ectopic growth hormone-releasing hormone secretion by a carcinoid bronchial tumor: a rare entity. J Thorac Cardiovasc Surg. 2004;128(4):631\u20132.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"9961_CR46","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1210\/endo.131.5.1425411","volume":"131","author":"SL Asa","year":"1992","unstructured":"Asa SL, Kovacs K, Stefaneanu L, et al. Pituitary adenomas in mice Transgenic for growth hormone-releasing hormone. Endocrinology. 1992;131(5):2083\u20139.","journal-title":"Endocrinology"},{"issue":"4","key":"9961_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2265.1987.tb01179.x","volume":"27","author":"PJ Smith","year":"1987","unstructured":"Smith PJ, Pringle PJ, Brook CG, Schulster D, Rafferty B. Plasma immunoreactive GHRH and serum GH concentrations following pulsatile GHRH 1\u201340 administration in GH deficient children. Clin Endocrinol (Oxf). 1987;27(4):501\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"9961_CR48","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/OP.21.00240","volume":"18","author":"JY Zhang","year":"2022","unstructured":"Zhang JY, Kunz PL. Making sense of a complex disease: A practical approach to managing neuroendocrine tumors. JCO Oncol Pract. 2022;18(4):258\u201364.","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"9961_CR49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/jcem.84.2.5497","volume":"84","author":"LJ Hofland","year":"1999","unstructured":"Hofland LJ, Liu Q, Van Koetsveld PM, et al. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors. J Clin Endocrinol Metab. 1999;84(2):775\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9961_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4158\/EP10165.CR","volume":"17","author":"DE Weiss","year":"2011","unstructured":"Weiss DE, Vogel H, Lopes MBS, Chang SD, Katznelson L. Ectopic acromegaly due to a pancreatic neuroendocrine tumor producing growth hormone-releasing hormone. Endocr Pract. 2011;17(1):79\u201384.","journal-title":"Endocr Pract"},{"issue":"2","key":"9961_CR51","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1210\/jcem-68-2-499","volume":"68","author":"DE Moller","year":"1989","unstructured":"Moller DE, Moses AC, Jones K, Thorner MO, Vance ML. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion. J Clin Endocrinol Metab. 1989;68(2):499\u2013504.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9961_CR52","first-page":"3483","volume":"5","author":"N Kimura","year":"1999","unstructured":"Kimura N, Pilichowska M, Date F, Kimura I, Schindler M. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin Cancer Res. 1999;5(11):3483\u20137.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"9961_CR53","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, et al. A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018;14(9):552\u201361.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"9961_CR54","doi-asserted-by":"publisher","first-page":"bvac083","DOI":"10.1210\/jendso\/bvac083","volume":"6","author":"B Rak-Makowska","year":"2022","unstructured":"Rak-Makowska B, Khoo B, Sen Gupta P, Plowman PN, Grossman AB, Korbonits M. Ockham\u2019s Razor for a retinal lesion and acromegaly and breaking the vicious circle. J Endocr Soc. 2022;6(7):bvac083.","journal-title":"J Endocr Soc"},{"issue":"2","key":"9961_CR55","doi-asserted-by":"publisher","first-page":"E251","DOI":"10.1210\/jc.2010-1742","volume":"96","author":"M Marazuela","year":"2011","unstructured":"Marazuela M, Paniagua AE, Gahete MD, et al. Somatotroph tumor progression during Pegvisomant therapy: a clinical and molecular study. J Clin Endocrinol Metab. 2011;96(2):E251\u2013259.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9961_CR56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2265.2009.03620.x","volume":"71","author":"PJ Trainer","year":"2009","unstructured":"Trainer PJ, Ezzat S, D\u2019Souza GA, Layton G, Strasburger CJ. A randomized, controlled, multicentre trial comparing Pegvisomant alone with combination therapy of Pegvisomant and long-acting octreotide in patients with acromegaly. Clin Endocrinol (Oxf). 2009;71(4):549\u201357.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"9961_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11102-006-0267-0","volume":"9","author":"M Gola","year":"2006","unstructured":"Gola M, Doga M, Bonadonna S, Mazziotti G, Vescovi PP, Giustina A. Neuroendocrine tumors secreting growth hormone-releasing hormone: pathophysiological and clinical aspects. Pituitary. 2006;9(3):221\u20139.","journal-title":"Pituitary"},{"issue":"9","key":"9961_CR58","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1210\/jcem.83.9.5088","volume":"83","author":"MR Drange","year":"1998","unstructured":"Drange MR, Melmed S. Long-acting Lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid. J Clin Endocrinol Metab. 1998;83(9):3104\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9961_CR59","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1002\/cam4.871","volume":"5","author":"T Shanmugalingam","year":"2016","unstructured":"Shanmugalingam T, Bosco C, Ridley AJ, Van Hemelrijck M. Is there a role for IGF-1 in the development of second primary cancers? Cancer Med. 2016;5(11):3353\u201367.","journal-title":"Cancer Med"},{"issue":"6","key":"9961_CR60","doi-asserted-by":"publisher","first-page":"P35","DOI":"10.1530\/EJE-21-1186","volume":"186","author":"MCS Boguszewski","year":"2022","unstructured":"Boguszewski MCS, Boguszewski CL, Chemaitilly W, et al. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement. Eur J Endocrinol. 2022;186(6):P35\u201352.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"9961_CR61","doi-asserted-by":"publisher","first-page":"e0285335","DOI":"10.1371\/journal.pone.0285335","volume":"18","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Xiao P, Wang Y, Fang C, Li Y. Risk of cancer in acromegaly patients: an updated meta-analysis and systematic review. PLoS ONE. 2023;18(11):e0285335.","journal-title":"PLoS ONE"},{"issue":"10","key":"9961_CR62","doi-asserted-by":"publisher","first-page":"e1092","DOI":"10.1210\/clinem\/dgad212","volume":"108","author":"T Mukama","year":"2023","unstructured":"Mukama T, Srour B, Johnson T, Katzke V, Kaaks R. IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all causes in EPIC-Heidelberg. J Clin Endocrinol Metab. 2023;108(10):e1092\u2013105.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"9961_CR63","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1073\/pnas.1533185100","volume":"100","author":"H Kiaris","year":"2003","unstructured":"Kiaris H, Chatzistamou I, Schally AV, et al. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Proc Natl Acad Sci U S A. 2003;100(16):9512\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9961_CR64","doi-asserted-by":"crossref","unstructured":"Gesmundo I, Pedrolli F, Cai R, Sha W, Schally AV, Granata R. Growth hormone-releasing hormone and cancer. Rev Endocr Metab Disord Published Online Oct 18, 2024.","DOI":"10.1007\/s11154-024-09919-4"},{"issue":"2","key":"9961_CR65","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1172\/JCI116639","volume":"92","author":"CA Jaffe","year":"1993","unstructured":"Jaffe CA, Friberg RD, Barkan AL. Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses. J Clin Invest. 1993;92(2):695\u2013701.","journal-title":"J Clin Invest"},{"issue":"2","key":"9961_CR66","first-page":"634","volume":"82","author":"CA Jaffe","year":"1997","unstructured":"Jaffe CA, DeMott-Friberg R, Frohman LA, Barkan AL. Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist. J Clin Endocrinol Metab. 1997;82(2):634\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"30","key":"9961_CR67","doi-asserted-by":"publisher","first-page":"10628","DOI":"10.1073\/pnas.0504102102","volume":"102","author":"G Keller","year":"2005","unstructured":"Keller G, Schally AV, Groot K, et al. Effective treatment of experimental human non-Hodgkin\u2019s lymphomas with antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A. 2005;102(30):10628\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9961_CR68","doi-asserted-by":"publisher","first-page":"170716","DOI":"10.1016\/j.peptides.2021.170716","volume":"150","author":"R Cai","year":"2022","unstructured":"Cai R, Zhang X, Wang H, et al. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity. Peptides. 2022;150:170716.","journal-title":"Peptides"},{"issue":"2","key":"9961_CR69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2005.01.008","volume":"226","author":"CA Kanashiro","year":"2005","unstructured":"Kanashiro CA, Schally AV, Varga JL, Hammann B, Halmos G, Zarandi M. Antagonists of growth hormone releasing hormone and Bombesin inhibit the expression of EGF\/HER receptor family in H-69 small cell lung carcinoma. Cancer Lett. 2005;226(2):123\u201331.","journal-title":"Cancer Lett"},{"issue":"12","key":"9961_CR70","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1210\/jc.2006-0610","volume":"91","author":"C Nasr","year":"2006","unstructured":"Nasr C, Mason A, Mayberg M, Staugaitis SM, Asa SL. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab. 2006;91(12):4776\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9961_CR71","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1210\/jcem-58-5-796","volume":"58","author":"SL Asa","year":"1984","unstructured":"Asa SL, Scheithauer BW, Bilbao JM, et al. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab. 1984;58(5):796\u2013803.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9961_CR72","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2265.1989.tb02229.x","volume":"30","author":"JS Bevan","year":"1989","unstructured":"Bevan JS, Asa SL, Rossi ML, Esiri MM, Adams CB, Burke CW. Intrasellar gangliocytoma containing Gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma. Clin Endocrinol (Oxf). 1989;30(3):213\u201324.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"9961_CR73","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1530\/ERC-11-0059","volume":"18","author":"C Villa","year":"2011","unstructured":"Villa C, Lagonigro MS, Magri F, et al. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to Aryl hydrocarbon receptor interacting protein gene mutation. Endocr Relat Cancer. 2011;18(3):347\u201356.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"9961_CR74","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1210\/jcem-64-3-585","volume":"64","author":"A Spada","year":"1987","unstructured":"Spada A, Elahi FR, Arosio M, et al. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly. J Clin Endocrinol Metab. 1987;64(3):585\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"9961_CR75","doi-asserted-by":"crossref","unstructured":"Melmed S, Acromegaly. N Engl J Med. 1990;322(14):966\u201377.","DOI":"10.1056\/NEJM199004053221405"},{"issue":"2","key":"9961_CR76","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/1097-0142(19880715)62:2<445::AID-CNCR2820620233>3.0.CO;2-5","volume":"62","author":"JA Ramsay","year":"1988","unstructured":"Ramsay JA, Kovacs K, Asa SL, Pike MJ, Thorner MO. Reversible Sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome. Cancer. 1988;62(2):445\u201350.","journal-title":"Cancer"},{"issue":"2","key":"9961_CR77","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1210\/jcem-60-2-392","volume":"60","author":"M Spero","year":"1985","unstructured":"Spero M, White EA. Resolution of acromegaly, amenorrhea-galactorrhea syndrome, and hypergastrinemia after resection of jejunal carcinoid. J Clin Endocrinol Metab. 1985;60(2):392\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9961_CR78","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/s-2002-32151","volume":"110","author":"M Bolanowski","year":"2002","unstructured":"Bolanowski M, Schopohl J, Marciniak M, et al. Acromegaly due to GHRH-secreting large bronchial carcinoid. Complete recovery following tumor surgery. Exp Clin Endocrinol Diabetes. 2002;110(4):188\u201392.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"9961_CR79","first-page":"e397","volume":"7","author":"S Sohail","year":"2021","unstructured":"Sohail S, Shafiq W, Sajjad K, Azmat U, Naveed MA. Ectopic acromegaly secondary to bronchial tumour: A case report of rare occurrence. J Cancer Allied Spec. 2021;7(1):e397.","journal-title":"J Cancer Allied Spec"},{"key":"9961_CR80","first-page":"21","volume":"2022","author":"M Koivikko","year":"2022","unstructured":"Koivikko M, Ebeling T, M\u00e4kinen M, et al. Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome. Endocrinol Diabetes Metab Case Rep. 2022;2022:21\u20130079.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"2","key":"9961_CR81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12022-009-9067-1","volume":"20","author":"N Colak Ozbey","year":"2009","unstructured":"Colak Ozbey N, Kapran Y, Bozbora A, Erbil Y, Tascioglu C, Asa SL. Ectopic growth hormone-releasing hormone secretion by a neuroendocrine tumor causing acromegaly: long-term follow-up results. Endocr Pathol. 2009;20(2):127\u201332.","journal-title":"Endocr Pathol"},{"issue":"7","key":"9961_CR82","first-page":"263","volume":"65","author":"CM de Jager","year":"2007","unstructured":"de Jager CM, de Heide LJM, van den Berg G, Wolthuis A, van Schelven WD. Acromegaly caused by a growth hormone-releasing hormone secreting carcinoid tumour of the lung: the effect of octreotide treatment. Neth J Med. 2007;65(7):263\u20136.","journal-title":"Neth J Med"},{"issue":"3","key":"9961_CR83","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11102-007-0045-7","volume":"10","author":"NR Biermasz","year":"2007","unstructured":"Biermasz NR, Smit JWA, Pereira AM, Fr\u00f6lich M, Romijn JA, Roelfsema F. Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients. Pituitary. 2007;10(3):237\u201349.","journal-title":"Pituitary"},{"issue":"3","key":"9961_CR84","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11102-007-0019-9","volume":"10","author":"P Fainstein Day","year":"2007","unstructured":"Fainstein Day P, Frohman L, Garcia Rivello H, et al. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a Non hypophysial intracranial tumor that shrank during long acting octreotide treatment. Pituitary. 2007;10(3):311\u20139.","journal-title":"Pituitary"},{"issue":"4","key":"9961_CR85","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/cen.14727","volume":"97","author":"CRC Pieterman","year":"2022","unstructured":"Pieterman CRC, Valk GD. Update on the clinical management of multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2022;97(4):409\u201323.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"9961_CR86","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","volume":"14","author":"JM de Laat","year":"2016","unstructured":"de Laat JM, van der Luijt RB, Pieterman CRC, et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016;14(1):182.","journal-title":"BMC Med"},{"issue":"3","key":"9961_CR87","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12020-023-03497-2","volume":"82","author":"RM Ruggeri","year":"2023","unstructured":"Ruggeri RM, Benevento E, De Cicco F, et al. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome. Endocrine. 2023;82(3):480\u201390.","journal-title":"Endocrine"},{"issue":"9","key":"9961_CR88","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990\u20133011.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"9961_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2152\/jmi.71.1","volume":"71","author":"R Yamasaki","year":"2024","unstructured":"Yamasaki R. Pancreatic GHRHomas in patients with or without multiple endocrine neoplasia type 1 (MEN 1): an analysis of 36 reported cases. J Med Invest. 2024;71(12):1\u20138.","journal-title":"J Med Invest"},{"issue":"4","key":"9961_CR90","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","volume":"106","author":"AJ Seabrook","year":"2021","unstructured":"Seabrook AJ, Harris JE, Velosa SB, et al. Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5? J Clin Endocrinol Metab. 2021;106(4):1163\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9961_CR91","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ando.2023.11.005","volume":"85","author":"N Sahakian","year":"2024","unstructured":"Sahakian N, Castinetti F, Romanet P, Reznik Y, Brue T. Updates on the genetics of multiple endocrine neoplasia. Ann Endocrinol (Paris). 2024;85(2):127\u201335.","journal-title":"Ann Endocrinol (Paris)"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09961-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-025-09961-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09961-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:07:41Z","timestamp":1757167661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-025-09961-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["9961"],"URL":"https:\/\/doi.org\/10.1007\/s11154-025-09961-w","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"24 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}